Literature-based automated discovery of tumor suppressor p53 phosphorylation and inhibition by NEK2
Scientific progress depends on formulating testable hypotheses informed by the literature. In many domains, however, this model is strained because the number of research papers exceeds human readability. Here, we developed computational assistance to analyze the biomedical literature by reading Pub...
Saved in:
Published in: | Proceedings of the National Academy of Sciences - PNAS Vol. 115; no. 42; pp. 10666 - 10671 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
National Academy of Sciences
16-10-2018
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Scientific progress depends on formulating testable hypotheses informed by the literature. In many domains, however, this model is strained because the number of research papers exceeds human readability. Here, we developed computational assistance to analyze the biomedical literature by reading PubMed abstracts to suggest new hypotheses. The approach was tested experimentally on the tumor suppressor p53 by ranking its most likely kinases, based on all available abstracts. Many of the best-ranked kinases were found to bind and phosphorylate p53 (P value = 0.005), suggesting six likely p53 kinases so far. One of these, NEK2, was studied in detail. A known mitosis promoter, NEK2 was shown to phosphorylate p53 at Ser315 in vitro and in vivo and to functionally inhibit p53. These bona fide validations of text-based predictions of p53 phosphorylation, and the discovery of an inhibitory p53 kinase of pharmaceutical interest, suggest that automated reasoning using a large body of literature can generate valuable molecular hypotheses and has the potential to accelerate scientific discovery. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 1B.-K.C., T.D., N.P., and A.D.W. contributed equally to this work. Edited by Carol Prives, Columbia University, New York, NY, and approved August 28, 2018 (received for review April 29, 2018) 2Present address: Department of Diagnostic and Biomedical Sciences, School of Dentistry at Houston, The University of Texas Health Science Center, Houston, TX 77054. Author contributions: B.-K.C., T.D., N.P., A.D.W., S.B., G.W., K.L.S., Y.C., S.S., L.A.D., and O.L. designed research; B.-K.C., T.D., N.P., A.D.W., M.N., I.B.N., B.J.B., S.Y.J., P.J.H., J.L.L., C.R.P., A.K.A., S.R., L.K., A.L., C.M.B., H.Z., and S.H.B. performed research; B.-K.C., T.D., N.P., A.D.W., M.N., I.B.N., B.J.B., S.Y.J., P.J.H., J.L.L., C.R.P., A.K.A., S.R., L.K., A.L., C.M.B., H.Z., S.H.B., and S.S. analyzed data; and B.-K.C., T.D., N.P., A.D.W., S.S., L.A.D., and O.L. wrote the paper. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.1806643115 |